MedPath

Safety and Efficacy clinical trial of the PTMA System to reduce mitral valve regurgitation in heart failure.

Recruiting
Conditions
Heart failure, Mitral valve, Mitral valve insufficiency, Mitral regurgitation, Valve disease
Registration Number
NL-OMON20121
Lead Sponsor
Viacor, Inc.
Brief Summary

http://www.viacorinc.com/bibliography.html

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

1. Moderate functional MR

2. Symptomatic heart failure

Exclusion Criteria

1. MR of organic origins

2. Severe mitral leaflet tethering

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
- Safety: freedom from MACE rate<br /><br>- Efficacy: Quantitative MR reduction at 6 months and device success.
Secondary Outcome Measures
NameTimeMethod
- Safety<br /><br>- Efficacy
© Copyright 2025. All Rights Reserved by MedPath